(Q52988044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tobias Fechter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Constantinos Zamboglou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gesche Wieser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Steffen Hennies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Irene Rempel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Simon Kirste

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Martin Soschynski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hans Christian Rischke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Cordula A Jilg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mathias Langer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Philipp T Meyer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anca-Ligia Grosu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

23 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

889-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592938%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-015-3257-5

1 March 2020

exact match

0 references

cites work

The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Choline PET based dose-painting in prostate cancer--modelling of dose effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

11C-Choline PET/pathology image coregistration in primary localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

(68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3257-5

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis

21 January 2018

1 reference

12 December 2020

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

1 reference

12 December 2020

Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy

1 reference

12 December 2020

Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis

1 reference

12 December 2020

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

12 December 2020

Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging

1 reference

12 December 2020

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

1 reference

12 December 2020

Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

1 reference

12 December 2020

Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis

1 reference

12 December 2020

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA

1 reference

12 December 2020